These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 1793059)

  • 1. Clinical aspects of inhaled anticholinergic therapy.
    Campbell SC
    Respir Care; 2000 Jul; 45(7):864-7. PubMed ID: 10926384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ; Bonner TI; Buckley CM; Brann MR
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypes.
    Burke RE
    Mov Disord; 1986; 1(2):135-44. PubMed ID: 2904117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD; Mash DC
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S; Buckley NJ; Roberts FF
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
    Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
    An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of muscarinic receptors in human, guinea pig and rat lung.
    Gies JP; Bertrand C; Vanderheyden P; Waeldele F; Dumont P; Pauli G; Landry Y
    J Pharmacol Exp Ther; 1989 Jul; 250(1):309-15. PubMed ID: 2746503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialorrhea Successfully Treated by the Combined Use of Selective M1 and M3 Muscarinic Acetylcholine Receptor Antagonists.
    Yamamura Y; Nonaka M
    J Nippon Med Sch; 2019; 86(2):117-121. PubMed ID: 31130562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiological basis for the use of muscarine antagonists in bronchopulmonary dysplasia].
    Fisher JT; Froese AB; Brundage KL
    Arch Pediatr; 1995; 2 Suppl 2():163S-171S. PubMed ID: 7633558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical efficacy and problems; muscarine M1 receptor blockaders].
    Yachi A; Yabana T; Takai Y
    Nihon Rinsho; 1988 Jan; 46(1):18-24. PubMed ID: 3373753
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a M1-selective muscarinic receptor antagonist (pirenzepine) on basal bronchomotor tone in young women.
    Fujimura M; Kamio Y; Matsuda T
    Respiration; 1992; 59(2):102-6. PubMed ID: 1620977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivation from the denervated human parotid gland induced by pirenzepine and telenzepine.
    Levin SL
    Eur J Clin Pharmacol; 1991; 41(6):613-4. PubMed ID: 1815976
    [No Abstract]   [Full Text] [Related]  

  • 16. Unexpected scaffold rearrangement product of pirenzepine found in commercial samples.
    Ozenil M; Skos L; Roller A; Gajic N; Holzer W; Spreitzer H; Platzer-Ozenil S; Vraka C; Hacker M; Wadsak W; Pichler V
    Sci Rep; 2021 Dec; 11(1):23397. PubMed ID: 34862437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose finding for bronchospasmolytic drugs in clinical practice (authors' transl)].
    Lichterfeld A
    Arzneimittelforschung; 1977 Feb; 27(2A):278-80. PubMed ID: 577175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor subtypes in airways.
    Barnes PJ; Minette P; Maclagan J
    Trends Pharmacol Sci; 1988 Nov; 9(11):412-6. PubMed ID: 3078078
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective muscarinic antagonists as bronchodilators.
    Doods HN
    Agents Actions Suppl; 1991; 34():117-30. PubMed ID: 1793059
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.